TU Delft and UMC Utrecht spinout MILabs has been purchased by Rigaku Corporation, which plans to use its medical imaging technology in drug development.
Scientific instrument producer Rigaku Corporation has paid an undisclosed amount to acquire MILabs, a Netherlands-based medical scanning system developer spun out of University Medical Center Utrecht and TU Delft.
MILabs has created a multimodal system that incorporates X-ray computed tomography (CT), positron emission tomography (PET), single-photon emission computed tomography (SPECT) and optical imaging capabilities.
Frederik Beekman, head of TU Delft’s Biomedical Imaging department, is the founder, chief executive and chief scientific officer of the company.
Thuja Capital…
